Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
29,997,317
-
Total 13F shares
-
4,039,425
-
Share change
-
-1,323,326
-
Total reported value
-
$2,463,897
-
Price per share
-
$0.61
-
Number of holders
-
30
-
Value change
-
-$820,496
-
Number of buys
-
10
-
Number of sells
-
8
Institutional Holders of EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share (EKSO) as of Q4 2024
As of 31 Dec 2024,
EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share (EKSO) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,039,425 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, Kent Lake PR LLC, VANGUARD GROUP INC, Cresset Asset Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, BlackRock, Inc., Compagnie Lombard Odier SCmA, NORTHERN TRUST CORP, and STATE STREET CORP.
This page lists
32
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.